HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA Reviewing Discounted REACH Fees To Ensure SMEs Truly Qualify

This article was originally published in The Rose Sheet

Executive Summary

The European Chemicals Agency will be asking companies that benefited from reduced fees on REACH registrations during the 2013-2015 period to provide documentation verifying their SME status. Registrants need to be checking REACH-IT regularly and potentially taking proactive measures to avoid penalties.

You may also be interested in...



REACH Information Requirements Have Changed; ECHA Preparing Guidance

The European Chemicals Agency is targeting the back half of 2022 for guidance on revised information requirements for substances registered under REACH, following a European Commission regulation published in March.

Never Mind IUCLID: Study Identifies Costs As Biggest Obstacle To SMEs’ REACH Registration

An ECHA-commissioned study finds the substantial cost of REACH compliance has SMEs considering portfolio rationalization, reduced production levels and other tactics to circumvent registration. According to ECHA, the study "confirms uncertainties" about SMEs' intentions as the May 31, 2018 phase-in deadline for low-tonnage chemicals draws closer, and the agency is exploring solutions accordingly.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121250

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel